Intrathecal Drug Delivery System: A Pain Management Option for Refractory Cancer-Related Pain

被引：3
作者：
Wanderman, Robalee L. [1 ]
Hagedorn, Jonathan M. [1 ]
机构：
[1] Mayo Clin, Div Pain Med, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA
来源：
PAIN MEDICINE | 2021年 / 22卷 / 02期
关键词：
Cancer Pain; Intrathecal Drug Delivery System; Opioids; CONFERENCE PACC RECOMMENDATIONS; THERAPY;
D O I：
10.1093/pm/pnaa364
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Cancer-related pain is progressive and therefore requires a stepwise approach to management, such as the World Health Organization's Pain Ladder. This approach calls for increasingly strong pain medications in addition to interventional options for patients with medication-refractory pain or intolerable medication side effects. Here, we discuss a case involving cancer-related pain which ultimately required intrathecal drug delivery system placement for optimal pain management.
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
  • [31] Strategies for interventional therapies in cancer-related paina crossroad in cancer pain management
    Allano, Gilles
    George, Brigitte
    Minello, Christian
    Burnod, Alexis
    Maindet, Caroline
    Lemaire, Antoine
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3133 - 3145
  • [32] Pharmacologic Management of Cancer-Related Pain, Dyspnea, and Nausea
    Cheung, Winson Y.
    Zimmermann, Camilla
    SEMINARS IN ONCOLOGY, 2011, 38 (03) : 450 - 459
  • [33] Current management strategy for cancer-related neuropathic pain
    Clere, Florentin
    MEDECINE PALLIATIVE, 2005, 4 (04): : 175 - 189
  • [34] Intrathecal drug-infusion system for treating pain in advanced cancer: New research in patient management
    Chen, Mei-gui
    Xiu, Min
    Yang, Lei
    Jin, Hai-yan
    Deng, Li-hua
    Li, Yi
    Chen, Peng
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (01) : 37 - 47
  • [35] Cancer-Related Neuropathic Pain
    Edwards, Helen L.
    Mulvey, Matthew R.
    Bennett, Michael I.
    CANCERS, 2019, 11 (03):
  • [36] Loss of effectiveness with an implanted drug delivery system for intrathecal pain therapy due to corrosion
    Reining, Marco
    Kretzschmar, Michael
    PAIN PRACTICE, 2023, 23 (04) : 459 - 462
  • [37] Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain
    Saulino, Michael
    Kim, Philip S.
    Shaw, Erik
    JOURNAL OF PAIN RESEARCH, 2014, 7 : 627 - 638
  • [38] Developing drugs in cancer-related bone pain
    Lucchesi, Maurizio
    Lanzetta, Gaetano
    Antonuzzo, Andrea
    Rozzi, Antonio
    Sardi, Iacopo
    Favre, Claudio
    Ripamonti, Carla Ida
    Santini, Daniele
    Armento, Grazia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 66 - 74
  • [39] Transdermal Buprenorphine in Children With Cancer-Related Pain
    Attina, Giorgio
    Ruggiero, Antonio
    Maurizi, Palma
    Arlotta, Annalisa
    Chiaretti, Antonio
    Riccardi, Riccardo
    PEDIATRIC BLOOD & CANCER, 2009, 52 (01) : 125 - 127
  • [40] Intrathecal Drug Delivery for Chronic Pain Syndromes: A Review of Considerations in Practice Management
    Abd-Elsayed, Alaa
    Karri, Jay
    Michael, Ashley
    Bryce, David
    Sun, Jennifer
    Lee, Maxwell
    Orhurhu, Vwaire
    Deer, Timothy
    PAIN PHYSICIAN, 2020, 23 (06) : E591 - E617
12345